The North America bioinoculants market was valued at USD 0.85 billion in 2025. This market is expected to reach USD 2.7 billion by 2036, growing from USD 0.94 billion in 2026, at a CAGR of 11.1% from 2026 to 2036.

The market covers microbial inoculants applied to seeds, soil, and plants to improve nutrient availability and crop growth, including nitrogen-fixing bacteria such as Rhizobium and Bradyrhizobium, phosphate-solubilizing microbes, mycorrhizal fungi, and plant-growth-promoting rhizobacteria. Demand is driven by the cost and volatility of synthetic fertilizer, by the growth of regenerative agriculture and soil-health practices, by sustainability and emissions goals, and by improving product performance on large-acreage row crops. The United States accounts for the large majority of regional demand, led by corn and soybean growers in the Midwest, and nitrogen-fixing inoculants are the dominant product type.

Key Highlights – North America Bioinoculants Market

• The North America bioinoculants market is expected to reach USD 2.7 billion by 2036, at a CAGR of 11.1% from 2026 to 2036, driven by fertilizer economics, regenerative agriculture, and improving product performance.
• Nitrogen fixation dominates the market. Nitrogen-fixing inoculants are projected to account for about 75% of the market in 2026, and Rhizobium alone captured about 33.65% of the U.S. biofertilizer market in 2025, reflecting decades of validated soybean and pulse performance.
• Fertilizer economics drive adoption. In the Midwest, where more than 75% of U.S. corn is grown, nitrogen is applied at high rates and Midwestern growers spent about USD 15.8 billion on fertilizer in 2022, giving microbial nitrogen a clear cost rationale.
• Microbial nitrogen is scaling on row crops. Pivot Bio products have been used on nearly 20 million acres across North America, with microbial nitrogen replacing up to 40 pounds of synthetic nitrogen per acre at about 60% lower cost, and field trials showing an average replacement of 33 pounds per acre with a yield gain.
• The Midwest leads adoption. Corn and soybean growers in Iowa, Illinois, and Nebraska led agricultural-biologicals demand in the United States in 2025, integrating nitrogen-fixing inoculants into row-crop acres.
• Product and policy momentum continued into 2026. In April 2026, Novonesis, through Novozymes North America, expanded its mycorrhiza-based inoculant portfolio to improve phosphorus uptake in corn and wheat, and USDA policy increasingly recognises biological nitrogen as a creditable practice.
• Key companies include Novonesis (Novozymes A/S), Pivot Bio, Inc., Corteva, Inc., BASF SE, and Bayer AG.

Report Overview

The North America bioinoculants market covers microbial inoculants applied to seeds, soil, and plants to improve nutrient availability and crop growth, including nitrogen-fixing bacteria, phosphate-solubilizing bacteria and mycorrhizal fungi, potassium-mobilizing microbes, and plant-growth-promoting rhizobacteria, supplied in liquid, carrier-based, and freeze-dried forms. It spans seed treatment and inoculation, soil treatment, and foliar application across cereals and grains, oilseeds and pulses, fruits and vegetables, and other crops. Chemical fertilizers and non-living biostimulants without a microbial inoculant are outside the scope. Demand is concentrated in the United States, led by corn and soybean growers in the Midwest, and is shaped by fertilizer economics, regenerative-agriculture adoption, and sustainability policy. This report examines the size, drivers, segmentation, countries, pricing, competition, recent developments, and outlook of the market, and provides recommendations for participants. Sizing is built bottom-up from crop acreage, inoculation rates, and product-level demand.

Key Market Dynamics

Market Drivers

The main drivers of the North America bioinoculants market are fertilizer cost and volatility, the growth of regenerative agriculture and soil-health practices, and improving product performance. Fertilizer economics are a direct driver: Midwestern growers, farming the region where more than 75% of U.S. corn is grown, spent about USD 15.8 billion on fertilizer in 2022, and microbial nitrogen products such as those from Pivot Bio, which replace up to 40 pounds of synthetic nitrogen per acre at about 60% lower cost, offer a clear economic case amid price volatility. Regenerative agriculture and soil-health practices are expanding, and seed-treatment platforms now commonly include microbial inoculants and nitrogen-fixing bacteria, with the Midwest leading agricultural-biologicals demand in 2025. Product performance is improving, with field trials showing consistent nitrogen displacement and yield gains, which builds grower confidence. Sustainability policy adds support, as USDA increasingly recognises biological nitrogen as a creditable practice and nitrogen management is a major source of agricultural emissions. These factors, fertilizer economics, regenerative agriculture, and improving performance, are the main drivers.

Key Opportunities

The market offers opportunities in microbial nitrogen for corn, in phosphate and mycorrhizal inoculants, and in the integration of inoculants into seed treatment. Microbial nitrogen for corn is the largest opportunity, because corn is the highest-nitrogen row crop and the Midwest spends billions on fertilizer, so replacing even a portion of synthetic nitrogen with microbial products on the tens of millions of corn acres is a substantial market, as Pivot Bio's near-20-million-acre adoption shows. Phosphate-solubilizing and mycorrhizal inoculants present a growing opportunity for phosphorus efficiency, illustrated by the April 2026 expansion of the Novonesis mycorrhiza portfolio for corn and wheat. The integration of inoculants into seed-treatment platforms, increasingly standard on large-acreage row crops, offers a scalable route to adoption. These areas, microbial nitrogen for corn, phosphate and mycorrhizal inoculants, and seed-treatment integration, are the main opportunities, alongside soybean and pulse inoculation and specialty-crop applications.

Market Trends

Current trends include the scaling of microbial nitrogen on row crops, the integration of inoculants into seed treatment, product performance improvement, and consolidation. Microbial nitrogen is scaling on corn and soybean acres, led by Midwest states such as Iowa, Illinois, and Nebraska, as growers respond to fertilizer cost and sustainability goals. Inoculants are increasingly delivered through seed-treatment platforms that also carry nitrogen-fixing bacteria and biostimulants, making application routine on large acreage. Product performance is improving, with field data showing reliable nitrogen displacement and yield gains, which is central to adoption in a performance-driven market. Consolidation is concentrating the field, illustrated by the agreement of Corteva Agriscience to acquire Symborg and by the formation of Novonesis from Novozymes and Chr. Hansen. These trends indicate a market moving from early adoption toward mainstream use on row crops.

Report Summary

Segmental Analysis

Market by Type

By type, the market comprises nitrogen-fixing inoculants, phosphate-solubilizing and mobilizing inoculants, mycorrhizae, and plant-growth-promoting rhizobacteria and others. Nitrogen-fixing inoculants hold the largest share, at about 75% of the market in 2026, with the remaining share divided across phosphate-solubilizing and mobilizing inoculants, mycorrhizae, and PGPR. Nitrogen-fixing inoculants, including Rhizobium and Bradyrhizobium for legumes and free-living and associative nitrogen fixers for cereals, are the dominant type because nitrogen is the highest-cost and highest-emission nutrient, and Rhizobium alone accounted for about a third of the U.S. biofertilizer market in 2025 on decades of soybean and pulse performance. Phosphate-solubilizing and mobilizing inoculants improve phosphorus availability. Mycorrhizae, symbiotic fungi that extend root systems, improve phosphorus and water uptake and are a growing segment. PGPR and other microbes promote growth and stress tolerance.

Market by Form

By form, the market comprises liquid, carrier-based, and freeze-dried and powder inoculants. Liquid inoculants hold the largest share, at about 50% of the market in 2026, with the remaining share divided between carrier-based and freeze-dried and powder forms. Liquid inoculants are favoured for ease of application, compatibility with seed-treatment and in-furrow equipment, and consistent microbial counts, and they suit large-acreage row-crop use. Carrier-based inoculants, including peat and granular carriers, are established in soybean and pulse inoculation and offer shelf stability. Freeze-dried and powder inoculants offer concentrated, stable products suited to seed coating and storage. The weighting toward liquid forms reflects the mechanisation and seed-treatment integration of row-crop agriculture.

Market by Application

By application, the market comprises seed treatment and inoculation, soil treatment, and foliar and other application. Seed treatment and inoculation hold the largest share, at about 55% of the market in 2026, with the remaining share divided between soil treatment and foliar application. Seed treatment is the leading application because it delivers inoculants efficiently at planting and is increasingly integrated into standard seed-treatment platforms on corn, soybean, and other row crops. Soil treatment, including in-furrow and broadcast application, delivers inoculants directly to the root zone and is used for both nitrogen and phosphate inoculants. Foliar and other applications serve specialty and in-season use. The dominance of seed treatment reflects its convenience and its fit with mechanised planting.

Market by Crop Type

By crop type, the market comprises oilseeds and pulses, cereals and grains, fruits and vegetables, and other crops. Oilseeds and pulses hold the largest share, at about 45% of the market in 2026, with the remaining share divided across cereals and grains, fruits and vegetables, and other crops. Oilseeds and pulses, led by soybean, are the most established market for inoculants because legumes form symbiotic nitrogen-fixing relationships with Rhizobium, and soybean inoculation is a long-standing practice. Cereals and grains, led by corn and wheat, are the fastest-growing crop segment as microbial nitrogen and phosphate inoculants scale on high-acreage row crops. Fruits and vegetables use inoculants for nutrient efficiency and soil health in higher-value production, and other crops complete the segment.

Geographic Analysis

United States Bioinoculants Market

The United States is by far the largest market in the region, accounting for the large majority of demand. The scale reflects the size of U.S. row-crop agriculture and the concentration of adoption in the Midwest, where more than 75% of U.S. corn is grown and where growers spent about USD 15.8 billion on fertilizer in 2022, giving microbial inoculants a strong economic rationale. Iowa, Illinois, and Nebraska led agricultural-biologicals demand in 2025, and microbial nitrogen products such as those from Pivot Bio have reached nearly 20 million acres. Supply is led by Novonesis, Pivot Bio, Inc., Corteva, Inc., BASF SE, and Bayer AG, and USDA policy increasingly recognises biological nitrogen as a creditable practice. The United States sets the pace for adoption, product development, and policy across the region.

Canada Bioinoculants Market

Canada is a significant secondary market with large acreages of soybean, canola, pulses, and cereals, and a long history of legume inoculation. Demand is driven by nitrogen-fixing inoculants for pulses and soybean, by phosphate and mycorrhizal inoculants, and by sustainability and soil-health goals in the Prairie provinces. Supply is drawn from the same multinational and specialist companies active in the United States, and Canadian growers and agronomy networks support inoculant use, particularly in pulse crops where inoculation is well established. The country's large pulse and oilseed base supports steady demand.

Pricing Analysis

Pricing in bioinoculants is shaped by product type, performance, and the cost of the synthetic inputs they replace. Nitrogen-fixing inoculants are priced against the cost of synthetic nitrogen, and their value proposition rests on delivering nutrient at lower cost, illustrated by microbial nitrogen products priced about 60% below synthetic nitrogen while replacing a share of it. Inoculant prices are modest relative to total input costs, but the return depends on reliable field performance, which is why field data and yield outcomes are central to how products are priced and adopted.

Several factors set price. Product type is central, with established Rhizobium inoculants for soybean and pulses priced competitively and newer microbial nitrogen and mycorrhizal products for corn and cereals carrying value tied to their performance and novelty. Performance and evidence increasingly determine price and adoption, since growers evaluate inoculants on nitrogen displacement, yield, and consistency. Form affects price, with liquid and freeze-dried products differing from carrier-based inoculants in cost and convenience. Crop and acreage matter, with high-acreage row crops supporting volume pricing and specialty crops higher margins. Distribution and integration into seed-treatment platforms influence pricing, and the cost and volatility of synthetic fertilizer set the benchmark against which inoculant value is measured, so periods of high fertilizer prices strengthen the economic case for inoculants.

Competitive Landscape

The competitive field combines large agricultural-input companies with specialist microbial and biologicals firms. Among the majors, Novonesis, formed from Novozymes and Chr. Hansen, is a leading microbial supplier and expanded its mycorrhiza-based inoculant portfolio in 2026; Corteva, Inc. has built a biologicals business including the acquisition of Symborg; and BASF SE, Bayer AG, and Syngenta Group offer inoculants and biologicals within broad crop-input portfolios. Lallemand Inc., through Lallemand Plant Care, is an established inoculant producer, and Certis Biologicals and Verdesian Life Sciences, LLC provide microbial and nutrient-efficiency products.

Among specialists, Pivot Bio, Inc. has led the scaling of microbial nitrogen on corn and soybean, reaching nearly 20 million acres, and Bioceres Crop Solutions Corp., through Rizobacter, is a major inoculant producer with strong positions in soybean and cereals. Indigo Agriculture, Inc. and BioConsortia, Inc. develop microbial products for nutrient use and crop performance. Competition turns on field-proven performance, distribution and seed-treatment integration, breadth of microbial portfolio, and the economic case against synthetic fertilizer. The scaling of microbial nitrogen, the growth of mycorrhizal and phosphate inoculants, and consolidation are expected to favour companies that combine proven products, distribution reach, and the ability to integrate inoculants into standard row-crop practice.

Key Players

The active companies in the market as of September 2026 include:

• Novonesis (Novozymes A/S)
• Pivot Bio, Inc.
• Corteva, Inc.
• BASF SE
• Bayer AG
• Syngenta Group
• Lallemand Inc.
• Certis Biologicals
• Verdesian Life Sciences, LLC
• Bioceres Crop Solutions Corp.
• Indigo Agriculture, Inc.
• BioConsortia, Inc.

Voice of Customer

Corn and soybean grower (United States, Midwest): "Fertilizer cost and volatility pushed me to try microbial nitrogen, and after a few seasons of on-farm strips I am comfortable replacing a portion of my synthetic nitrogen. The product has to deliver yield and be easy to apply with my seed treatment, and the economics only work if the performance is consistent year to year."

Agronomist, farm cooperative (United States): "Inoculants have moved from a soybean practice to a whole-farm conversation, including nitrogen and phosphorus on corn and wheat. What growers ask for is field data from their region and their soils, not general claims. We recommend products with a track record and a clear return against fertilizer cost."

Pulse grower (Canada, Prairies): "Inoculating pulses is standard practice here and has been for years, so the base is well established. The newer interest is in phosphate and mycorrhizal products and in getting more from the same acres. Reliability and shelf stability matter because our application window is short."

Analyst Perspective

North American bioinoculants is a market moving from early adoption toward mainstream use on row crops, driven by concrete farm economics rather than sentiment. Fertilizer cost and volatility give microbial nitrogen a clear economic case, particularly in the Midwest where corn dominates and fertilizer spending runs to billions of dollars, and products that replace a share of synthetic nitrogen at lower cost while maintaining yield have reached tens of millions of acres. Nitrogen fixation dominates the market at about three-quarters of demand, and the established soybean and pulse inoculant base provides a foundation on which newer corn and cereal products are building.

The defining variable for the market is field performance and grower confidence. Inoculants are living products whose results vary with soil, weather, and management, and adoption depends on consistent, regionally relevant field data rather than general claims; this is both the main risk and the main path to growth. The economic case strengthens when fertilizer prices are high and weakens when they fall, so the market is partly tied to fertilizer markets. Policy support, including USDA recognition of biological nitrogen as a creditable practice, adds a durable driver, and consolidation is concentrating capability among companies that combine proven products with distribution and seed-treatment integration. Companies that pair field-validated performance with distribution reach and a clear return against synthetic fertilizer are best positioned as inoculants move into standard row-crop practice.

Key Strategic Developments

• April 2026: Novonesis, through Novozymes North America, expanded its mycorrhiza-based inoculant portfolio with enhanced fungal products designed to improve phosphorus uptake in corn and wheat, extending microbial nutrient-efficiency products beyond nitrogen fixation.
• 2026: Pivot Bio released field-performance data showing consistent yield gains and synthetic-nitrogen displacement while lowering fertilizer costs, with products used on nearly 20 million acres across North America and microbial nitrogen replacing up to 40 pounds of synthetic nitrogen per acre.
• 2026: Midwest states including Iowa, Illinois, and Nebraska continued to lead agricultural-biologicals demand as corn and soybean growers integrated nitrogen-fixing inoculants into row-crop acres.
• 2025-2026: USDA policy increasingly recognised biological nitrogen as a creditable regenerative-agriculture practice, and support for climate-smart and regenerative practices reinforced the case for microbial inoculants.
• Through the first three quarters of 2026: Consolidation continued, with the biologicals business of Corteva Agriscience, including the acquisition of Symborg, and the integration of Novozymes and Chr. Hansen into Novonesis, concentrating microbial capability among the majors.

Strategic Recommendations

For companies, the priority is to build and communicate field-validated, regionally relevant performance, because inoculants are living products and adoption depends on consistent results and a clear return against synthetic fertilizer rather than general claims. Companies should scale proven microbial nitrogen products for corn and soybean, expand phosphate and mycorrhizal inoculants for phosphorus efficiency, and integrate inoculants into standard seed-treatment platforms to make application routine on large acreage. Aligning products with USDA regenerative-agriculture and climate-smart programs strengthens the economic and policy case.

For growers and agronomists, the recommendation is to evaluate inoculants on regional field data and return against fertilizer cost, adopting proven products at a pace that fits on-farm testing, and to use inoculants as part of an integrated nutrient and soil-health strategy rather than a standalone input. For policymakers, the evidence supports continued recognition of biological nitrogen as a creditable practice, given its potential to reduce fertilizer cost and nitrogen emissions. For investors, this is a market to evaluate on field-proven performance, distribution reach, and the economic case against synthetic fertilizer rather than on broad sustainability claims, recognising that fertilizer economics and grower confidence drive adoption while the shift toward regenerative practice provides a durable tailwind.